Basic mechanisms responsible for osteolytic and osteoblastic bone metastases

被引:387
作者
Guise, Theresa A.
Mohammad, Khalid S.
Clines, Gregory
Stebbins, Elizabeth G.
Wong, Darren H.
Higgins, Linda S.
Vessella, Robert
Corey, Eva
Padalecki, Susan
Suva, Larry
Chirgwin, John M.
机构
[1] Univ Virginia, Dept Med, Div Endocrinol, Charlottesville, VA 22903 USA
[2] Scios Inc, Fremont, CA USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
关键词
D O I
10.1158/1078-0432.CCR-06-1007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Certain solid tumors metastasize to bone and cause osteolysis and abnormal new bone formation. The respective phenotypes of dysregulated bone destruction and bone formation represent two ends of a spectrum, and most patients will have evidence of both. The mechanisms responsible for tumor growth in bone are complex and involve tumor stimulation of the osteoclast and the osteoblast as well as the response of the bone microenvironment. Furthermore, factors that increase bone resorption, independent of tumor, such as sex steroid deficiency may contribute to this vicious cycle of tumor growth in bone. This article discusses mechanisms and therapeutic implications of osteolytic and osteoblastic bone metastases.
引用
收藏
页码:6213S / 6216S
页数:4
相关论文
共 26 条
  • [1] Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-κB ligand pathway
    Bendre, MS
    Margulies, AG
    Walser, B
    Akel, NS
    Bhattacharrya, S
    Skinner, RA
    Swain, F
    Ramani, V
    Mohammad, KS
    Wessner, LL
    Martinez, A
    Guise, TA
    Chirgwin, JM
    Gaddy, D
    Suva, LJ
    [J]. CANCER RESEARCH, 2005, 65 (23) : 11001 - 11009
  • [2] Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors
    Brown, JE
    Cook, RJ
    Major, P
    Lipton, A
    Saad, F
    Smith, M
    Lee, KA
    Zheng, M
    Hei, YJ
    Coleman, RE
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (01): : 59 - 69
  • [3] Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: A randomized, phase II, placebo-controlled trial
    Carducci, MA
    Padley, RJ
    Breul, J
    Vogelzang, NJ
    Zonnenberg, BA
    Daliani, DD
    Schulman, CC
    Nabulsi, AA
    Humerickhouse, RA
    Weinberg, MA
    Schmitt, JL
    Nelson, JB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (04) : 679 - 689
  • [4] Clines GA, 2005, J BONE MINER RES, V20, pS249
  • [5] Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid
    Coleman, RE
    Major, P
    Lipton, A
    Brown, JE
    Lee, KA
    Smith, M
    Saad, F
    Zheng, M
    Hei, YJ
    Seaman, J
    Cook, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 4925 - 4935
  • [6] Proteolysis of latent transforming growth factor-β (TGF-β)-binding protein-1 by osteoclasts -: A cellular mechanism for release of TGF-β from bone matrix
    Dallas, SL
    Rosser, JL
    Mundy, GR
    Bonewald, LF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) : 21352 - 21360
  • [7] Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis
    Guise, TA
    Yin, JJ
    Taylor, SD
    Kumagai, Y
    Dallas, M
    Boyce, BF
    Yoneda, T
    Mundy, GR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (07) : 1544 - 1549
  • [8] Transforming growth factor-β stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways
    Käkönen, SM
    Selander, KS
    Chirgwin, JM
    Yin, JJ
    Burns, S
    Rankin, WA
    Grubbs, BG
    Dallas, M
    Cui, Y
    Guise, TA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (27) : 24571 - 24578
  • [9] Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway
    Kang, YB
    He, W
    Tulley, S
    Gupta, GP
    Serganova, I
    Chen, CR
    Manova-Todorova, K
    Blasberg, R
    Gerald, WL
    Massagué, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (39) : 13909 - 13914
  • [10] A multigenic program mediating breast cancer metastasis to bone
    Kang, YB
    Siegel, PM
    Shu, WP
    Drobnjak, M
    Kakonen, SM
    Cordón-Cardo, C
    Guise, TA
    Massagué, J
    [J]. CANCER CELL, 2003, 3 (06) : 537 - 549